Skip to content

The Effect of Hyperbaric Oxygen Therapy on Retina in Patients with Type 2 Diabetes Mellitus

The Effect of Hyperbaric Oxygen Therapy on Retina in Patients with Type 2 Diabetes Mellitus

Status
Unknown
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20210809003
Enrollment
60
Registered
2021-08-09
Start date
2021-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic retinopathy in patients with type 2 diabetes mellitus Diabetic retinopathy, Hyperbaric Oxygen Therapy

Interventions

Type 2 DM patients who have scheduled for a course of hyperbaric oxygen therapy,Type 2 DM patients without indication of hyperbaric oxygen therapy who were matched with group 1 patients in terms of di
Treatment,Treatment
Type 2 DM patients who will undergo HBOT,Type 2 DM patients who will not undergo HBOT

Sponsors

Faculty of Medicine Siriraj Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Male or female aged 18 years old of age and above 2. Diagnosed as diabetes mellitus type 2 3. New patients who have indication for hyperbaric oxygen treatment for the first time and will be treated by hyperbaric oxygen 2.4 ATA at least 30 times (90 minutes/time).

Exclusion criteria

Exclusion criteria: 1.Patients cannot be investigated by OCT and others ophthalmological devices. 2.Patients have significant ocular media opacity. 3.Patients used to treated by hyperbaric oxygen. 4.Patients used to undergo surgery vitrectomy. 5.Patients have been treated by focal laser or grid laser before. 6.Pateints have been undergone intraocular surgery , Intravitreous injection and panretinal photocoagulation within 6 months. 7.Patinets have macular diseases which affect results of OCTA. 8.Pateints have uncontrollable cardiovascular diseases such us hypertensive urgency.

Design outcomes

Primary

MeasureTime frame
Retinal vessel on OCTA at start of HBOT, at session 11th, 21st, and 30th of HBOT, and at 2 weeks after the end of HBOT OCTA Metrics

Secondary

MeasureTime frame
Fundus findings on OCT at start of HBOT, at session 11th, 21st, and 30th of HBOT, and at 2 weeks after the end of HBOT OCT Metrics,Diabetic retinopathy staging at start of HBOT, at session 11th, 21st, and 30th of HBOT, and at 2 weeks after the end of HBOT Fundus photograph

Countries

Thailand

Contacts

Public ContactAsst. Prof.Supalert Prakhunhungsit

Faculty of Medicine Siriraj Hospital, Mahidol University

off_sp25@hotmail.com0814441734

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026